Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature

European Addiction Research

Volumn 22, Issue 3, 2016, Pages 131-144

  Schlossarek, Samantha ^a   Kempkensteffen, Jürgen ^b   Reimer, Jens ^a   Verthein, Uwe ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cannabis dependence; Cannabis use; Psychosocial determinants; Risk factors

Indexed keywords

CANNABIS;

CANNABIS ADDICTION; CANNABIS USE; CORRELATIONAL STUDY; DSM-IV; EMBASE; HUMAN; ICD-10; MEDLINE; PARENTAL DEPRIVATION; PRIORITY JOURNAL; PSYCINFO; REVIEW; SOCIAL ENVIRONMENT; SOCIAL PSYCHOLOGY; STRESS; SYSTEMATIC REVIEW; COMORBIDITY; MARIJUANA ABUSE; MENTAL DISORDERS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; RISK FACTOR;

COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MARIJUANA ABUSE; MENTAL DISORDERS; RISK FACTORS;

EID: 84946711362     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000441777     Document Type: Review

References (73)

1. Budney AJ, Lile JA: Moving beyond the can-nabis controversy into the world of the can-nabinoids. Int Rev Psychiatry 2009; 21:91-95.
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): European drug report 2014: trends and developments. 2014. http://www.emcdda.europa.eu/publications/edr/trends-developments/2014.
3. Reuter PH: Marijuana legalization: what can be learned from other countries. Santa Monica, RAND: Drug Policy Research Center, 2010. http://www.rand.org/content/dam/rand/pubs/working-papers/2010/RAND-WR771. pdf.
4. Van den Brink W: Forum: decriminalization of cannabis. Curr Opin Psychiatry 2008; 21: 122-126.
5. Bonnet U, Scherbaum N: Cannabisbezogene Störungen. Teil II: Psychiatrische und soma-tische Folgestörungen und Komorbiditäten [Cannabis use disorders. Part II: psychiatric and somatic sequelae and comorbidities]. Fortschr Neurol Psychiatr 2010; 78: 360-367; quiz 368.
6. Soellner R, Gabriel U: Typisch "Kiffer"? Stereotype und Personenwahrnehmung [Typical pothead? Stereotypes and person perception]. Sucht 2008; 54:32-37.
7. Jager G: Cannabis; in Verster J, Brady K, Galanter M, Conrod P (eds): Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. New York, Springer, 2012, pp 151-162.
8. Murray RM, Morrison PD, Henquet C, Di Forti M: Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007; 8:885-895.
9. Bostwick JM: Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 2012; 87:172-186.
10. Grotenhermen F, Müller-Vahl K: The therapeutic potential of cannabis and cannabi-noids. Dtsch Arztebl Int 2012; 109:495-501.
11. Pacher P, Bátkai S, Kunos G: The endocan-nabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58: 389-462.
12. Congressional Research Service: State legalization of recreational marijuana: selected legal issues. 2014. http://fas.org/sgp/crs/misc/R43034.pdf.
13. Hawken A, Caulkins J, Kilmer B, Kleiman M: Quasi-legal cannabis in Colorado and Washington: local and national implications. Addiction 2013; 108:837-838.
14. Sevigny EL, Pacula RL, Heaton P: The effects of medical marijuana laws on potency. Int J Drug Policy 2014; 25:308-319.
15. Bonnet U, Scherbaum N: Cannabisbezogene Störungen. Teil I: Pharmakologie, Epidemi-ologie und Therapieverfahren [Cannabis use disorders. Part I: pharmacology, epidemiology and therapy]. Fortschr Neurol Psychiatr 2010; 78:297-305.
16. National Survey on Drug Use and Health (NSDUH): Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. 2012. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.pdf.
17. United Nations Office on Drugs and Crime (UNODC): World drug report 2014. https://www.unodc.org/documents/wdr2014/World-Drug-Report-2014-web.pdf.
18. Kraus L, Pabst A, Piontek D, Müller S: Trends des Substanzkonsums und substanzbezogener Störungen. Ergebnisse des Epidemiologischen Suchtsurveys 1995-2009 [Trends of substance use and substance use disorders. Results of the 2009 epidemiological survey of substance abuse 1995-2009]. Sucht 2010; 56:337-347.
19. Liebregts N, Benschop A, van Der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ: Cannabis dependence and peer selection in social networks of frequent users. Contemporary Drug Problems 2011; 38:93-120.
20. Noack R, Höfler M, Lueken U: Cannabis use patterns and their association with DSM-IV cannabis dependence and gender. Eur Addict Res 2011; 17:321-328.
21. Pabst A, Kraus L, Gomes de Matos E, Piontek D: Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012 [Substance use and substance use disorders in Germany in 2012]. Sucht 2013; 59:321-331.
22. Lopez-Quintero C, Pérez de los Cobos J, Ha-sin DS, Okuda M, Wang S, Grant BF, Blanco C: Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2010; 115:120-130.
23. Murphy A, Taylor E, Elliott R: The detrimental effects of emotional process dysregulation on decision-making in substance dependence. Front Integr Neurosci 2012; 6:101.
24. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
25. American Psychiatric Association (APA): Substance-related and addictive disorders. American Psychiatric Association, 2013. http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20 Sheet.pdf.
26. World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, ed 2. Geneva, WHO, 2004.
27. Nutt DJ, King LA, Phillips LD; Independent Scientific Committee on Drugs: Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376:1558-1565.
28. Van Amsterdam J, Opperhuizen A, Koeter M, Van den Brink W: Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res 2010; 16:202-207.
29. Cascone P, Zimmermann G, Auckenthaler B, Robert-Tissot C: Cannabis dependence in Swiss adolescents: exploration of the role of anxiety, coping styles, and psychosocial difficulties. Swiss J Psychol 2011; 70:129-139.
30. Timberlake DS: A comparison of drug use and dependence between blunt smokers and other cannabis users. Subst Use Misuse 2009; 44:401-415.
31. Taylor DR, Fergusson DM, Milne BJ, Hor-wood LJ, Moffitt TE, Sears MR, Poulton R: A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97: 1055-1061.
32. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151:264-269.
33. van der Pol P, Liebregts N, De Graaf R, Ten Have M, Korf DJ, van den Brink W, van Laar M: Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction 2013; 108:1459-1469.
34. Patton GC, Coffey C, Carlin JB, Sawyer SM, Wakefield M: Teen smokers reach their mid twenties. J Adolesc Health 2006; 39:214-220.
35. Redner R, White TJ, Harder VS, Higgins ST: Vulnerability to smokeless tobacco use among those dependent on alcohol or illicit drugs. Nicotine Tob Res 2014; 16:216-223.
36. Coffey C, Carlin JB, Lynskey M, Li N, Patton GC: Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry 2003; 182:330-336.
37. Swift W, Coffey C, Carlin JB, Degenhardt L, Patton GC: Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 2008; 103:1361-1370.
38. Stinson FS, Ruan WJ, Pickering R, Grant BF: Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 2006; 36:1447-1460.
39. Nocon A, Wittchen HU, Pfister H, Zimmer-mann P, Lieb R: Dependence symptoms in young cannabis users? A prospective epide-miological study. J Psychiatr Res 2006; 40: 394-403.
40. Smucker Barnwell SV, Earleywine M, Gordis EB: Confirming alcohol-moderated links between cannabis use and dependence in a national sample. Addict Behav 2006; 31:1695-1699.
41. Von Sydow K, Lieb R, Pfister H, Höfler M, Wittchen HU: What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend 2002; 68:49-64.
42. Chen CY, O'Brien MS, Anthony JC: Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 2005; 79:11-22.
43. Gao K, Chan PK, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Bilali S, Brady KT, Findling RL, Calabrese JR: Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. Am J Addict 2010; 19:440-449.
44. Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED: Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy 2008; 28:156-169.
45. Pacek LR, Martins SS, Crum RM: The bidirectional relationships between alcohol, canna-bis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord 2013; 148:188-195.
46. Libby AM, Orton HD, Stover SK, Riggs PD: What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort. Addict Behav 2005; 30:1649-1662.
47. Kaynak O, Meyers K, Caldeira KM, Vincent KB, Winters KC, Arria AM: Relationships among parental monitoring and sensation seeking on the development of substance use disorder among college students. Addict Be-hav 2013; 38:1457-1463.
48. Marmorstein NR, Iacono WG: Longitudinal follow-up of adolescents with late-onset antisocial behavior: a pathological yet overlooked group. J Am Acad Child Adolesc Psychiatry 2005; 44:1284-1291.
49. Flory K, Milich R, Lynam DR, Leukefeld C, Clayton R: Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of atten-tion-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav 2003; 17:151-158.
50. Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM: Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res 2008; 42:230-239.
51. Khantzian EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142:1259-1264.
52. Swift W, Hall W, Copeland J: One year follow-up of cannabis dependence among long-term users in Sydney, Australia. Drug Alcohol Depend 2000; 59:309-318.
53. Swift W, Coffey C, Carlin JB, Degenhardt L, Calabria B, Patton GC: Are adolescents who moderate their cannabis use at lower risk of later regular and dependent cannabis use? Addiction 2009; 104:806-814.
54. Van der Pol P, Liebregts N, De Graaf R, Korf DJ, Van den Brink W, Van Laar M: Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 2013; 133: 352-359.
55. Fergusson DM, Horwood LJ, Lynskey MT, Madden PA: Early reactions to cannabis predict later dependence. Arch Gen Psychiatry 2003; 60:1033-1039.
56. Le Strat Y, Ramoz N, Horwood J, Falissard B, Hassler C, Romo L, Choquet M, Fergusson D, Gorwood P: First positive reactions to canna-bis constitute a priority risk factor for canna-bis dependence. Addiction 2009; 104:1710-1717.
57. Blevins CE, Stephens RS, Walker DD, Roff-man RA: Situational determinants of use and treatment outcomes in marijuana dependent adults. Addict Behav 2014; 39:546-552.
58. Fox CL, Towe SL, Stephens RS, Walker DD, Roffman RA: Motives for cannabis use in high-risk adolescent users. Psychol Addict Behav 2011; 25:492-500.
59. Liebregts N, van Der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ: The role of study and work in cannabis use and dependence trajectories among young adult frequent cannabis users. Front Psychiatry 2013; 4:85.
60. Silver E, Arseneault L, Langley J, Caspi A, Moffitt TE: Mental disorder and violent victimization in a total birth cohort. Am J Public Health 2005; 95:2015-2021.
61. Smucker Barnwell S, Earleywine M, Gordis EB: Alcohol consumption moderates the link between cannabis use and cannabis dependence in an internet survey. Psychol Addict Behav 2005; 19:212-216.
62. Johnson K, Mullin JL, Marshall EC, Bonn-Miller MO, Zvolensky M: Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict 2010; 19:277-282.
63. Zvolensky MJ, Bernstein A, Sachs-Ericsson N, Schmidt NB, Buckner JD, Bonn-Miller MO: Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. J Psychiatr Res 2006; 40:477-486.
64. Chabrol H, Ducongé E, Casas C, Roura C, Carey KB: Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005; 30:829-840.
65. Clark CB, Perkins A, McCullumsmith CB, Islam MA, Hanover EE, Cropsey KL: Characteristics of victims of sexual abuse by gender and race in a community corrections population. J Interpers Violence 2012; 27:1844-1861.
66. Dorard G, Berthoz S, Phan O, Corcos M, Bun-gener C: Affect dysregulation in cannabis abusers: a study in adolescents and young adults. Eur Child Adolesc Psychiatry 2008; 17: 274-282.
67. Lynskey MT, Heath AC, Nelson EC, Bucholz KK, Madden PA, Slutske WS, Statham DJ, Martin NG: Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med 2002; 32:195-207.
68. Lynskey MT, Glowinski AL, Todorov AA, Bucholz KK, Madden PA, Statham DJ, Martin NG, Heath AC: Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004; 61:1026-1032.
69. Mathews RR, Hall WD, Gartner CE: Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med J Aust 2011; 195:S12-S15.
70. Noack R, Höfler M, Gründler R, Becker A, Schulz R, Paul K: Konsummuster als Kovari-ablen von DSM-IV Cannabisabhängigkeit [Relationships between cannabis use patterns and DSM-IV cannabis dependence]. Sucht 2009; 55:137-147.
71. Ream GL, Benoit E, Johnson BD, Dunlap E: Smoking tobacco along with marijuana increases symptoms of cannabis dependence. Drug Alcohol Depend 2008; 95:199-208.
72. Chen CY, Anthony JC: Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use. Addiction 2003; 98:71-82.
73. Swift W, Hall W, Didcott P, Reilly D: Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction 1998; 93:1149-1160.